# Genetic Testing * **Definition:** The analysis of DNA, RNA, chromosomes, genes, or proteins to identify changes that may be associated with a specific disease or condition, assess the risk of inherited conditions, or provide insights into an individual's health. * **Taxonomy:** Healthcare Topics / Genetic Testing ## News * Selected news on the topic of **Genetic Testing**, for healthcare technology leaders * 8.8K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/20/2025 | [**Predictive Genetic Testing And Consumer & Wellness Genomics Market Insights Report**](https://www.linkedin.com/pulse/predictive-genetic-testing-consumer-wellness-genomics-ae1be/) | [[Linkedin]] | | 4/24/2025 | [**At-Home Genetic Testing Market to Reach $4.5 Bn By 2027 in the short run and ... - PR Newswire**](https://www.prnewswire.com/news-releases/at-home-genetic-testing-market-to-reach-4-5-bn-by-2027-in-the-short-run-and-20-2-bn-by-2035-globally-at-20-3-cagr-allied-market-research-302437306.html) | [[PR Newswire]] | | 4/7/2025 | [**Top innovative projects at health systems - Becker's Hospital Review - Healthcare News & Analysis**](https://www.beckershospitalreview.com/innovation/top-innovative-projects-at-health-systems/) | [[Beckers Hospital Review]] | | 4/6/2025 | [**Top projects from Fortune's most innovative health systems**](https://www.beckershospitalreview.com/healthcare-information-technology/innovation/top-innovative-projects-at-health-systems/) | [[Beckers Hospital Review]] | | 3/26/2025 | [**Direct-to-Consumer Genetic Testing Market Size Set to Reach $7.19 Billion by 2030, Driven ...**](https://finance.yahoo.com/news/direct-consumer-genetic-testing-market-135000105.html) | [[Yahoo Finance]] | | 1/23/2025 | [**Predictive Genetic Testing and Consumer Genomics Market Research 2024-2034 - Yahoo Finance**](https://finance.yahoo.com/news/predictive-genetic-testing-consumer-genomics-104200858.html) | [[Yahoo Finance]] | | 1/14/2025 | [**Wellness Genomics Market Forecast Report 2024-2032: Lucrative Opportunities with ...**](https://finance.yahoo.com/news/wellness-genomics-market-forecast-report-090100666.html) | [[Yahoo Finance]] | | 1/4/2025 | [**The Top 50 Healthcare Technology CEOs of 2024**](https://thehealthcaretechnologyreport.com/the-top-50-healthcare-technology-ceos-of-2024/) | [[Healthcare Technology Report]] | | 12/30/2024 | [**Precision Medicine Software Research Analysis Report 2024-2030: Increasing Adoption of Genomic Data Analysis Software Spurs Growth, Integration of Multi-Omics Data Strengthens the Business Case - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241230952002/en/Precision-Medicine-Software-Research-Analysis-Report-2024-2030-Increasing-Adoption-of-Genomic-Data-Analysis-Software-Spurs-Growth-Integration-of-Multi-Omics-Data-Strengthens-the-Business-Case---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/30/2024 | [**Precision Medicine Software Research Analysis Report 2024-2030: Increasing Adoption of Genomic Data Analysis Software Spurs Growth, Integration of Multi-Omics Data Strengthens the Business Case - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241230952002/en/Precision-Medicine-Software-Research-Analysis-Report-2024-2030-Increasing-Adoption-of-Genomic-Data-Analysis-Software-Spurs-Growth-Integration-of-Multi-Omics-Data-Strengthens-the-Business-Case---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/24/2024 | [**Precision Medicine Software Research Analysis Report 2024: Market to Reach $4.4 Billion ...**](https://finance.yahoo.com/news/precision-medicine-software-research-analysis-132900381.html) | [[Yahoo Finance]] | | 12/21/2024 | [**Patau Syndrome Genetic Testing Market Size And Forecast: Industry Overview and Future Outlook**](https://www.linkedin.com/pulse/patau-syndrome-genetic-testing-market-size-forecast-akrwc) | [[Linkedin]] | | 11/27/2024 | [**Fragile X Syndrome Genetic Testing Market Consumer Behavior Insights - LinkedIn**](https://www.linkedin.com/pulse/fragile-x-syndrome-genetic-testing-market-consumer-loeqe/) | [[Linkedin]] | | 11/25/2024 | [**Latest Hereditary Genetic Testing Market Report: Size, Share, and Revenue Analysis with ...**](https://www.linkedin.com/pulse/latest-hereditary-genetic-testing-market-report-size-share-qv2rf) | [[Linkedin]] | | 11/21/2024 | [**Preimplantation Genetic Testing for Monogenic & Single Gene Defects Kits Market Analysis 2024**](https://www.linkedin.com/pulse/preimplantation-genetic-testing-monogenic-single-gene-defects-nhjsf) | [[Linkedin]] | | 11/19/2024 | [**Trends in State and Federal Regulation of Consumer Genetic Testing**](https://www.jdsupra.com/legalnews/trends-in-state-and-federal-regulation-7440045/) | [[JD Supra]] | | 11/11/2024 | [**Population Health Management Market to Grow by USD 22.55 Billion from 2024-2028 ...**](https://www.prnewswire.com/news-releases/population-health-management-market-to-grow-by-usd-22-55-billion-from-2024-2028--driven-by-rising-adoption-of-healthcare-it-report-with-ai-impact-on-trends---technavio-302300769.html) | [[PR Newswire]] | | 11/10/2024 | [**Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence**](https://medcitynews.com/2024/11/driving-genetic-testing-adoption-and-improved-patient-care-through-health-data-intelligence/) | [[MedCity News]] | | 11/6/2024 | [**Saudi Arabia Genetic Testing Market and 10 Year Forecast Report 2019-2029 ... - Yahoo Finance**](https://finance.yahoo.com/news/saudi-arabia-genetic-testing-market-100500770.html) | [[Yahoo Finance]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences ...**](https://www.businesswire.com/news/home/20241008712158/en/SEQSTER-CEO-Ardy-Arianpour-Named-to-PharmaVoice-100-for-Innovation-in-Life-Sciences-for-a-Second-Consecutive-Year) | [[Business Wire]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences for a Second Consecutive Year**](http://www.businesswire.com/news/home/20241008712158/en/SEQSTER-CEO-Ardy-Arianpour-Named-to-PharmaVoice-100-for-Innovation-in-Life-Sciences-for-a-Second-Consecutive-Year/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/8/2024 | [**SEQSTER CEO Ardy Arianpour Named to PharmaVoice 100 for Innovation in Life Sciences ...**](https://www.morningstar.com/news/business-wire/20241008712158/seqster-ceo-ardy-arianpour-named-to-pharmavoice-100-for-innovation-in-life-sciences-for-a-second-consecutive-year) | [[Morningstar]] | | 8/12/2024 | [**Hereditary Genetic Testing Market Analysis, Competitive Landscape and Forecasts, 2024-2033: Expansion into Emerging Markets, Increasing Inorganic Growth Activities to Bolster Growth - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20240812228669/en/Hereditary-Genetic-Testing-Market-Analysis-Competitive-Landscape-and-Forecasts-2024-2033-Expansion-into-Emerging-Markets-Increasing-Inorganic-Growth-Activities-to-Bolster-Growth---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 7/29/2024 | [**Should people with kidney disease get genetic testing?**](https://medicalxpress.com/news/2024-07-people-kidney-disease-genetic.html) | [[MedicalXpress]] | | 6/19/2024 | [**PreCheck Health Services announce Webinar on Advancing Care Through Revolutionary Genetic Testing**](https://www.prnewswire.com/news-releases/precheck-health-services-announce-webinar-on-advancing-care-through-revolutionary-genetic-testing-302174787.html) | [[PR Newswire]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Genea Biomedx**: A company specializing in IVF technologies, collaborating to enhance success rates through genetic testing. - **Gattaca Genomics**: Partnering with Genea Biomedx to improve IVF outcomes through genetic testing. - **Myriad Genetics, Inc.**: A leader in genetic testing, focusing on reproductive and prenatal genetic testing, as well as hereditary cancer testing. - **GeneDx Holdings**: A company recognized for its performance in the genetic testing market, focusing on genomic analysis. - **Nucleus Genomics**: A company that provides advanced genetic testing capabilities and aims to democratize access to genetic screening. - **Myriad Genetics**: A leader in genetic testing and precision medicine, known for pioneering tests that assess disease risk. - **3X4 Genetics**: A genetic testing company that offers personalized genetic testing services, including the 3X4 Blueprint. - **Fulgent Genetics**: A company awarded a contract by the U.S. Department of Veterans Affairs to provide hereditary cancer and pharmacogenetic testing services. - **Natera**: A genetic testing company collaborating with AKF to raise awareness about genetic testing in kidney disease. - **Labcorp**: A global leader in laboratory services, enhancing genetic testing solutions for oncology and rare diseases. - **Baylor Genetics**: A leading provider of genetic testing and lab services, recognized for its commitment to innovation and accuracy in genetic testing. - **Telos PGX**: A leader in pharmacogenetic testing, enhancing personalized medication solutions. - **Availity**: The largest real-time health information network in the U.S., partnering with Concert to streamline genetic testing processes. - **Genomics Plc**: Collaborating with Vertex Pharmaceuticals to discover and develop new precision medicines using proprietary genetic tools. - **HealthLynked**: A healthcare technology company that has partnered with 3X4 Genetics to provide personalized genetic insights and advanced genetic testing services. ### Partnerships and Collaborations - **Genea Biomedx and Gattaca Genomics**: Collaborating on a study to enhance IVF success rates through time-lapse imaging and genetic testing. - **Myriad Genetics and Flatiron Health**: Integrated MyRisk Hereditary Cancer Test into Flatiron's OncoEMR platform to enhance access to genetic testing. - **Sanford Health**: Launching a genetic screening research study called ImagineYou, offering free genetic testing for hereditary conditions. - **St. Jude Lab and PreCheck Health Services**: Hosting a webinar to educate healthcare providers about advancements in genetic testing. - **Epic and GeneDx**: Integration of rapid whole genome sequencing services into Epic's platform for neonatal care. - **Availity and Concert**: Partnered to digitize and automate prior authorization and payment processes for genetic tests, enhancing consistency and transparency. - **Labcorp and Invitae**: A partnership aimed at leveraging genetic insights to improve patient care and treatment options. - **Parkview Regional Medical Center and Helix**: Collaborating to utilize genetic testing to identify patients at risk for diseases like breast cancer and heart disease. - **Principle Health Systems and Telos PGX**: An acquisition to enhance personalized medication solutions through pharmacogenetic testing. - **Ubie and Nucleus Genomics**: Partnering to enhance access to genetic screening and early disease detection through AI-powered tools. - **Tempus AI and Ambry Genetics**: Acquisition to enhance Tempus's testing capabilities and expand disease coverage. - **AKF and Natera**: Collaboration to promote genetic testing awareness for kidney disease through the 'Answers Unlocked' campaign. - **Huntsman Cancer Institute and NYU Langone Perlmutter Cancer Center**: Researching the use of a specialized chatbot to assist patients in deciding on genetic testing for cancer risk. - **Genomics Plc and Vertex Pharmaceuticals**: Extending collaboration to develop new precision medicines with a focus on better patient identification and biomarker selection. - **BGI Genomics and Technopark Biogen**: Opened the Astana Genetic Center in Kazakhstan to improve early disease diagnosis and preventive medicine. - **MEDIROM Healthcare Technologies and Japan Gene Medicine Corporation**: MEDIROM plans to acquire a 70% stake in Japan Gene Medicine, focusing on prenatal genetic testing. - **HealthLynked and 3X4 Genetics**: This strategic partnership aims to enhance healthcare services and provide personalized genetic insights to members. - **Truveta Genome Project**: A collaboration among multiple health systems and pharmaceutical companies to create a large database of genetic information. ### Innovations, Trends, and Initiatives - **Integration of Genetic Testing in Pediatric Care**: A UCLA Health study showed that incorporating genetic testing in evaluating pediatric patients with neurodevelopmental disorders led to more personalized care. - **Universal Genetic Testing for Breast Cancer**: A study advocating for universal genetic testing to ensure no patients are overlooked for advanced therapies. - **Direct-to-Consumer Testing**: Growing trend in genetic testing, driven by increased consumer awareness and demand for proactive health management. - **Direct-to-Consumer Genetic Testing**: Experiencing significant growth due to advancements in NGS technologies and increasing consumer interest in personalized healthcare. - **Technological Advancements**: AI-powered testing and next-generation sequencing are key trends enhancing genetic testing efficiency and accessibility. - **Advancements in Genetic Testing Technologies**: Technological improvements, particularly in next-generation sequencing (NGS), driving market growth and enhancing testing accuracy. - **Pharmacogenomic Testing**: Integrating PGx testing into prostate cancer care to personalize treatments and optimize drug dosages. - **Chatbot for Genetic Counseling**: A study showing that a chatbot can effectively assist patients in deciding on genetic testing, expanding access to genetic care. - **Myogenes Clozapine Test**: A genetic test aimed at improving treatment for patients with treatment-resistant schizophrenia. - **AI and Big Data in Genetic Testing**: Leveraging AI and big data analytics to enhance genomic data collection and analysis, leading to improved predictive modeling and personalized patient recommendations. - **Market Growth**: The North America genetic testing services market is projected to reach $4.98 billion by 2030, driven by the prevalence of genetic diseases and acceptance of personalized medicine. - **Preimplantation Genetic Testing (PGT)**: Expected to grow significantly due to advancements in genetic screening technologies and increasing demand for IVF treatments. - **Educational Initiatives**: Myriad Genetics launched 'Know More Sooner' to provide information about prenatal genetic testing and dispel myths. - **Unlock Behind the Seizure Program by Invitae**: Aiming to provide affordable genetic testing for pediatric epilepsy to shorten the diagnostic process. - **AI in Genetic Testing**: Artificial intelligence is expected to enhance predictive analytics and personalized medicine, improving patient outcomes. - **Hyper-Personalized Medicine**: An approach that tailors treatments based on genetic makeup, environment, and lifestyle, leveraging advancements in genomics. - **Pharmacogenomics**: Growing interest in integrating genetic information into prescribing practices to enhance medication effectiveness and reduce side effects. - **AI-Driven Genomic Analysis**: The integration of AI technologies in genomic analysis is transforming precision medicine, enabling personalized treatment pathways. ### Challenges and Concerns - **Ethical Implications of Genetic Testing**: Concerns regarding the limitations of genetic tests in providing comprehensive information for clinical decisions. - **Ethical Implications of Free Genetic Testing**: Need for careful consideration of clinical, ethical, and legal implications to protect patient data. - **Access to Genetic Testing**: Many eligible patients, such as breast cancer survivors, are not receiving genetic counseling and testing. - **Privacy Concerns**: Direct-to-consumer genetic testing raises significant privacy issues regarding the handling of personal genetic data. - **Ethical Concerns in Genetic Data**: The use of genetic data raises privacy and ethical concerns, particularly regarding accessibility and the high costs of genetic testing. - **Regulatory Issues**: Gaps in genetic data privacy protection prompt states to regulate direct-to-consumer genetic testing companies. - **Education Gaps**: Only 10% of genetic tests are ordered by genetic counselors, indicating a need for improved education among healthcare providers. - **Ethical Concerns**: Ongoing discussions about the ethical implications of genetic testing and embryo manipulation in PGT. - **Data Privacy and Security**: Concerns regarding the security and privacy of genomic data, which could hinder the growth of genetic testing markets. - **Data Privacy**: Direct-to-consumer genetic testing companies face scrutiny over privacy and data security practices, especially after significant data breaches. - **Cost Barriers**: High initial costs of advanced genetic testing technologies may hinder adoption in smaller laboratories and emerging markets. - **Insurance Disparities**: Racial inequities in access to genetic testing, with studies showing lower completion rates among Black children due to higher insurance denial rates. - **Patient Awareness**: A general lack of understanding among patients regarding consent and the implications of genetic testing. - **Shortage of Trained Professionals**: The growing demand for genetic testing and personalized medicine is challenged by a shortage of trained professionals in the field. - **Regulatory Frameworks**: The need for robust regulations to address health risks and complexities associated with genetic disorders. - **Regulatory Hurdles**: Challenges faced by the Fragile X Syndrome Genetic Testing market due to intense competition and the necessity for continuous innovation. - **Insurance Discrimination**: The fear of life insurance denial has deterred individuals from seeking genetic testing, highlighting the need for regulatory changes. ## Related Topics [[Genetic Pathology]]; [[Clinical Genomics]]; [[Clinical Genetics]]; [[Laboratory Genetics]]; [[Genomic Analysis]]; [[Medical Genetics]]; [[Genomics]]; [[Laboratory Genomics]]